Synthesis of indazole based diarylurea derivatives and their antiproliferative activity against tumor cell lines

Cui-rong Zhao1, Rui-qi Wang, Gang Li

  • 1Department of Pharmacology, School of Pharmaceutical Sciences, Shandong University, Wen Hua Xi Rd, Jinan 250012, China.

Insights

New indazole-based diarylureas show potent anticancer activity, outperforming sorafenib against various cancer cell lines. Specific derivatives with trifluoromethyl or halogen substituents exhibit enhanced efficacy and lower toxicity.

Area of Science:

  • Medicinal Chemistry
  • Organic Synthesis
  • Pharmacology

Background:

  • Diarylureas represent a significant class of compounds with demonstrated anticancer properties.
  • Sorafenib, a multi-kinase inhibitor, serves as a benchmark for anticancer drug efficacy.
  • Exploring novel chemical scaffolds is crucial for developing more effective cancer therapeutics.

Purpose of the Study:

  • To synthesize and evaluate a new series of indazole-based diarylurea derivatives for their anticancer potential.
  • To compare the efficacy of these novel compounds against a panel of human cancer cell lines with the established drug sorafenib.
  • To investigate the structure-activity relationships, particularly the influence of substituents on the indazole ring.

Main Methods:

  • Synthesis of a novel series of indazole-based diarylurea compounds.
  • In vitro anticancer activity screening against a diverse panel of human cancer cell lines (H460, A549, OS-RC-2, HT-29, Lovo, HepG2, Bel-7402, SGC-7901, MDA-MB-231).
  • Acute toxicity assessment of select compounds and comparison with sorafenib.

Main Results:

  • Most synthesized indazole-based diarylureas demonstrated superior or comparable anticancer activity to sorafenib across multiple cell lines.
  • Derivatives featuring trifluoromethyl or halogen substituents on the indazole ring exhibited enhanced potency.
  • Compounds 5a, 5b, and 5i showed reduced acute toxicity compared to sorafenib, with compound 5i displaying the most significant anticancer effects.

Conclusions:

  • Indazole-based diarylureas represent a promising class of anticancer agents.
  • Strategic substitution on the indazole core, particularly with trifluoromethyl groups, can significantly enhance anticancer potency and potentially improve safety profiles.
  • Compound 5i is identified as a lead candidate for further development due to its potent anticancer activity and favorable toxicity profile.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Aryldiazonium Salts to Azo Dyes: Diazo Coupling01:11

Aryldiazonium Salts to Azo Dyes: Diazo Coupling

The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the para position.
Oral Hypoglycemic Agents: Sulfonylureas01:17

Oral Hypoglycemic Agents: Sulfonylureas

Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide (Glucotrol),...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...